Capital Market on MSN
Alembic Pharma gets USFDA final approval for Dasatinib tablets in multiple strengths
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Sprycel Tablets, of Bristol-Myers Squibb Company (BMS). Dasatinib is indicated for adult patients with newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback